Clinical Trials · NCT02416271
The Forteo Alendronate Comparator Trial
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 203
- Start date
- Apr 2001
- Locations
- 20 sites, 4 countries
- Primary endpoint
- Percent Change from Baseline to 18 Months in Lumbar Spine BMD